publication date: Jun. 29, 2018
NCI Director’s Report What NCI did with the money: Sharpless boosts funding for RPGs, centers, SPOREs, NCTN, and NCORP
By Matthew Bin Han Ong
In addition to a $147 million increase to the Research Project Grant pool, NCI has added $60 million to targeted research opportunities and a $20 million increase for centers and SPOREs, and $10 million for the National Clinical Trials Network and the NCI Community Oncology Research Program.
The institute received a $275 million increase over fiscal 2017 levels, bringing NCI’s enacted 2018 budget to $5.66 billion. Of the new funds, NCI leadership invested over half into the RPG pool.
“You can see that there was about almost a $40 million increase in taps, benefits, and salaries,” NCI Director Ned Sharpless said at the June 26 joint meeting of the National Cancer Advisory Board and the Board of Scienific Advisors. “These are things that the NCI has to experience. There’s an increase to our [Small Business Innovation Research program] funding, it’s a fixed grade of our external budget.”
NCI stands to receive an additional $190 million in FY19—out of a $2 billion increase for NIH—if the latest version of the Senate appropriations bill for Labor-HHS is enacted.
Over 20 percent of NCI’s FY18 increase was allocated to specific research opportunities. … Continue reading What NCI did with the money: Sharpless boosts funding for RPGs, centers, SPOREs, NCTN, and NCORP
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.